Suppr超能文献

具备经皮冠状动脉介入治疗能力的医院中,ST段抬高型心肌梗死患者再灌注策略及医院死亡率的时间趋势

Temporal Trends of Reperfusion Strategies and Hospital Mortality for Patients With STEMI in Percutaneous Coronary Intervention-Capable Hospitals.

作者信息

Tran Dat T, Welsh Robert C, Ohinmaa Arto, Thanh Nguyen X, Kaul Padma

机构信息

School of Public Health, University of Alberta, Edmonton, Alberta, Canada.

Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Mazankowski Alberta Heart Institute, University of Alberta Hospital, Edmonton, Alberta, Canada; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Can J Cardiol. 2017 Apr;33(4):485-492. doi: 10.1016/j.cjca.2016.12.002. Epub 2016 Dec 8.

Abstract

BACKGROUND

The aim of this study was to examine temporal trends and provincial variations in reperfusion strategies and in-hospital mortality among patients presenting with ST-segment elevation myocardial infarction (STEMI) at hospitals in Canada capable of performing percutaneous coronary intervention (PCI).

METHODS

We included patients aged ≥ 20 years who were hospitalized between fiscal years 2009 and 2013 in all provinces except Quebec. We categorized patients as receiving fibrinolysis (lysis), primary PCI (pPCI), or no reperfusion. Patients undergoing lysis were further categorized as (1) lysis + PCI ≤ 90 minutes, (2) lysis + PCI > 90 minutes, and (3) lysis only. Patients undergoing pPCI were further categorized as (1) pPCI ≤ 90 minutes and (2) pPCI > 90 minutes. We used logistic regression to examine the baseline-adjusted association between reperfusion strategy and in-hospital mortality.

RESULTS

Among 44,650 STEMI episodes in 44,373 patients, 66.3% received pPCI (annual increase of 7.8%; P < 0.001). British Columbia had the highest (81.4%) rates of pPCI and New Brunswick had the lowest rates (30.2%). In-hospital mortality ranged from a high of 16.3% among patients receiving no reperfusion to a low of 1.9% among patients receiving lysis + PCI > 90 minutes (adjusted odds ratio of 0.42; 95% confidence interval, 0.32-0.55 compared with pPCI ≤ 90 minutes).

CONCLUSIONS

The use of pPCI in STEMI has increased significantly in Canada; however, significant interprovincial variation remains. Changes in reperfusion strategies do not appear to have had an impact on in-hospital mortality rates. Patients who underwent lysis followed by PCI in a systematic fashion had the lowest mortality.

摘要

背景

本研究旨在调查加拿大有能力进行经皮冠状动脉介入治疗(PCI)的医院中,ST段抬高型心肌梗死(STEMI)患者再灌注策略和院内死亡率的时间趋势及省级差异。

方法

我们纳入了2009财年至2013财年期间除魁北克省外所有省份住院的年龄≥20岁的患者。我们将患者分为接受纤溶治疗(溶栓)、直接PCI(pPCI)或未进行再灌注治疗。接受溶栓治疗的患者进一步分为:(1)溶栓+PCI≤90分钟;(2)溶栓+PCI>90分钟;(3)仅溶栓。接受pPCI的患者进一步分为:(1)pPCI≤90分钟;(2)pPCI>90分钟。我们使用逻辑回归分析再灌注策略与院内死亡率之间经基线调整后的关联。

结果

在44373例患者的44650次STEMI发作中,66.3%接受了pPCI(年增长率为7.8%;P<0.001)。不列颠哥伦比亚省的pPCI使用率最高(81.4%),新不伦瑞克省的使用率最低(30.2%)。院内死亡率范围从未接受再灌注治疗患者的16.3%到接受溶栓+PCI>90分钟患者的1.9%(与pPCI≤90分钟相比,调整后的优势比为0.42;95%置信区间为0.32-0.55)。

结论

加拿大STEMI患者中pPCI的使用显著增加;然而省份间仍存在显著差异。再灌注策略的改变似乎对院内死亡率没有影响。以系统方式接受溶栓后再行PCI的患者死亡率最低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验